Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-15-053840
Filing Date
2015-07-28
Accepted
2015-07-28 16:21:24
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a15-16298_110qa.htm 10-Q/A 1259751
2 EX-31.3 a15-16298_1ex31d3.htm EX-31.3 13321
3 EX-31.4 a15-16298_1ex31d4.htm EX-31.4 13376
4 EX-32.3 a15-16298_1ex32d3.htm EX-32.3 6210
5 EX-32.4 a15-16298_1ex32d4.htm EX-32.4 6274
  Complete submission text file 0001104659-15-053840.txt   4952911

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opht-20150331.xml EX-101.INS 979155
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opht-20150331.xsd EX-101.SCH 37042
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opht-20150331_cal.xml EX-101.CAL 33437
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opht-20150331_def.xml EX-101.DEF 134209
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT opht-20150331_lab.xml EX-101.LAB 354277
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opht-20150331_pre.xml EX-101.PRE 261132
Mailing Address ONE PENN PLAZA 19TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 19TH FLOOR NEW YORK NY 10119 212-845-8200
Ophthotech Corp. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36080 | Film No.: 151009938
SIC: 2834 Pharmaceutical Preparations